By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


aTyr Pharma Inc. 

10685 Road to the Cure
Suite 100
San Diego  California  92121  U.S.A.
Phone: 858-731-8389 Fax: 858-731-8394



Start Up

Company News
aTyr Pharma Announces Third Quarter 2015 Operating Results 11/11/2015 8:46:01 AM
aTyr Pharma Selects Second IND Candidate, The First Engineered Physiocrine For GMP Process Development And For Potential Treatment Of Severe Lung Diseases 11/11/2015 7:16:20 AM
aTyr Pharma To Host Breakout Session At The 6th Annual World Orphan Drug Congress 11/10/2015 9:45:51 AM
aTyr Pharma Initiates Phase 1b/2 Clinical Trial In Patients With Early Onset FSHD 11/9/2015 7:39:52 AM
Nature Release: Publication In aTyr Pharma Demonstrates Physiocrine Genetic Mutation Disrupts A Key Signaling Pathway In Neuronal Biology 11/4/2015 7:22:29 AM
aTyr Pharma To Present At 24th Annual Credit Suisse Healthcare Conference 11/3/2015 7:27:42 AM
aTyr Pharma Initiates Phase 1b/2 Clinical Trial For Patients With Limb Girdle Muscular Dystrophy 2B 10/13/2015 6:12:17 AM
aTyr Pharma Announces Presentations At The World Muscle Congress And 10th International Symposium On Aminoacyl-Trna Synthetases (AARS2015) 9/25/2015 10:39:55 AM
aTyr Pharma Doses First Patient In Long-Term Safety Extension Study Of Resolaris For Treatment Of Adult Patients With FSHD 9/10/2015 6:17:45 AM
aTyr Pharma Announces Transitions In Clinical Development & Operations 7/20/2015 9:13:27 AM